AbbVie stock climbs after Upadacitinib approval filings with FDA and EMA

AbbVie stock climbs after Upadacitinib approval filings with FDA and EMA  Traders Union

Summary aggregated from Traders Union's public RSS feed. The full reporting belongs to Traders Union — please read it on their site.